Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009 Results

Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009
Results

WALTHAM, Mass., Nov. 5 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc.
(NYSE Amex: ILI) announced today that it will host a conference call and
webcast on Thursday, November 12, 2009, at 4:30 p.m. EST to review the
Company's business developments and third quarter financial results.

To access the live call, dial 888-287-5529 (domestic) or 719-325-2486
(international). The live webcast and replay access of the teleconference will
be available on the Investors section of the Company's website at
http://www.ilgenetics.com.

About Interleukin Genetics
Interleukin Genetics, Inc. (NYSE Amex: ILI) develops and markets genetic tests
under the Inherent Health(TM) brand that empower consumers to prevent chronic
diseases and assists pharmaceutical companies in the development and marketing
of targeted therapeutics. The Company leverages its research, intellectual
property and biomarker development experience to facilitate the emerging
personalized health market. Interleukin Genetics is headquartered in Waltham,
MA. For more information please visit www.ilgenetics.com.

SOURCE Interleukin Genetics, Inc.

Media, Erin Walsh of Interleukin Genetics, +1-781-419-4707,
ewalsh@ilgenetics.com